The biological functions of high-density lipoproteins (HDLs) contribute to explaining the cardioprotective role of the lipoprotein beyond quantitative HDL cholesterol levels. A few small-scale interventions with a single antioxidant have improved some HDL functions. However, to date, no long-term, large-scale, randomized controlled trial has been conducted to assess the effects of an antioxidant-rich dietary pattern (such as a traditional Mediterranean diet [TMD]) on HDL function in humans.
A growing and consistent body of evidence (from observational and randomized controlled trials) supports that the traditional Mediterranean diet (TMD) protects against the development of cardiovascular diseases. 1 The PREDIMED Study (Prevención con Dieta Mediterránea), a multicenter, parallel, randomized controlled trial, has been crucial for showing this protection in primary cardiovascular disease prevention. 2, 3 Several mechanisms may contribute to explain the protection of this traditional food pattern against atherosclerosis such as its ability to preserve DNA and systemic lipids against oxidative modifications, its anti-inflammatory effects, its modulatory capacity on the metabolomic profile, and its capacity to modulate gene expression related to cardiovascular diseases. [4] [5] [6] [7] The TMD has also improved the lipid profile related to high-density lipoproteins (HDLs). 8, 9 However, it is becoming increasingly more accepted that HDL function may reflect the antiatherogenic role of the lipoprotein better than HDL cholesterol (HDL-C) levels. 10 Several foods and nutrients present in the TMD have been shown to improve a number of HDL functions in humans in previous trials.
11 -14 To date, however, no evidence of the effects of the whole TMD on HDL properties has been reported.
The aim of the present study was to determine, in a random subsample of the PREDIMED Study, whether the long-term consumption of a TMD, enriched with virgin olive oil or nuts, was able to improve the different HDL functional properties in humans.
METHODS
An extended description of methods is available in the onlineonly Data Supplement.
Study Population
Considering the available samples of the PREDIMED Study 2, 15 and the sample size calculation estimated before the experiments, we performed a random selection of individuals with biological samples at baseline and after 1 year of dietary intervention (n=296, 4.14% of the volunteers of the total trial). Volunteers had been randomly assigned in the beginning of the study to 1 of the following 3 interventions: a TMD enriched with virgin olive oil (TMD-VOO; n=100), a TMD enriched with nuts (TMD-Nuts; n=100), and a low-fat control diet (n=96). We also registered the changes in general clinical and sociodemographic variables, adherence to the TMD, a food frequency questionnaire from the previous year, and physical activity. 15 The local Research and Ethics Committee approved the protocol of the study. Volunteers gave informed consent before joining the trial.
HDL Functions and Quality-Related Properties
We determined the volunteers' biochemical profile (glucose, triglycerides, total cholesterol, HDL-C, apolipoprotein A-I [ApoA-I], and apolipoprotein B) in an ABX-Pentra 400 autoanalyzer (Horiba ABX). 11 We calculated low-density lipoprotein (LDL) cholesterol levels with the Friedewald formula (when triglycerides were <300 mg/dL) 16 and the HDL-C/ApoA-I and apolipoprotein B/ApoA-I ratios. We isolated HDL particles from the plasma of the participants by density gradient ultracentrifugation 11 or by polyethylene glycol precipitation of apolipoprotein B-containing lipoproteins. 17 We measured cholesterol efflux capacity in a model of human THP-1 monocyte-derived macrophages. 11 We calculated the capacity of HDL particles to esterify cholesterol (the HDL-C esterification index) as follows: percentage of esterified cholesterol in HDL divided by mass of lecithin-cholesterol transfer protein (LCAT; measured in plasma as previously reported 18 ). We assessed the activity of cholesteryl ester transfer protein (CETP) in plasma and the arylesterase activity of paraoxonase-1 (PON1) in serum in commercial kits. 11, 18 We measured HDL antioxidant capacity as the ability of HDL to decrease the formation of conjugated dienes in LDLs in a pro-oxidant environment 16 in a random subselection of 90 volunteers. HDL inflammatory index (HII) was based on the oxidation of the fluorescent 2',7'-dichlorodihydrofluorescein. 19 We determined HDL vasodilatory capacity as the HDL-induced increase in nitric oxide production in human umbilical vein endothelial cells. 20 The level of oxidative modifications in HDL particles (the HDL oxidation index) was measured as follows: equivalents of malondialdehyde in HDL 21 divided by cholesterol in HDL. We assessed the resistance of HDL lipoprotein against oxidation (HDL oxidation lag time in a pro-oxidant environment) in a random subsample of 90 volunteers. 16 We assessed HDL composition (total cholesterol, free cholesterol, esterified cholesterol, triglycerides, phospholipids, ApoA-I, and apolipoproteins A-II and C-III) in isolated HDL samples in an ABX-Pentra 
Sample Size

Main Sample
A sample size of 96 participants per group allowed ≥80% power to detect a significant difference of 0.025 points in normalized cholesterol efflux capacity values between preintervention and postintervention values and of 0.035 points among the 3 interventions, considering a 2-sided type I error of 0.05, a loss rate of 5%, and the standard deviation of the differences in cholesterol efflux capacity (SD=0.084) after an analogous dietary intervention.
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Subgroup for HDL Antioxidant Capacity and HDL Resistance Against Oxidation
Because we had no previous data available on these properties, we calculated this sample size considering the variability of the differences in the activity of the main HDL antioxidant enzyme (PON1) after an analogous dietary intervention. 22 A sample size of 28 participants per group allowed ≥80% power to detect a significant difference of 0.057 points in the previous normalized capacity between preintervention and postintervention values and of 0.08 points among the 3 interventions, considering a 2-sided type I error of 0.05, a loss rate of 5%, and the standard deviation of the differences in this property (SD=0.104). 22 
Statistical Analyses
We checked the distribution of continuous variables in normality plots and by the Shapiro-Wilk test and log-transformed the nonnormally distributed variables. We looked for differences between our subsample and the whole PREDIMED population by a t test and for differences in the baseline values among the 3 intervention groups by a χ 2 test (categorical variables) or a 1-way ANOVA (continuous variables).
We analyzed differences between preintervention and postintervention values in every intervention by a paired t test. We checked the effects of the 3 interventions on the changes in the variables of interest in a multivariate linear regression analysis (using 2 dummy variables, 1 for each intervention group), in which we included as covariables sex, age, participant's center of origin (k−1 dummy variables), baseline value of the variable, and changes in the presence of dyslipidemia, type 2 diabetes mellitus, hypertension, and smoking habit throughout the study.
To assess the relationships among HDL functional parameters in baseline values, we performed Spearman correlation analyses among variables and a principal component analysis. Moreover, to study the relationships among the changes in HDL functional parameters after the TMD-VOO intervention (the one in which most of the changes in HDL functions took place), we performed Spearman correlation analyses among these differences, a principal component analysis, and multivariate linear regression analyses adjusted for the changes in other HDL functions (together with the variables described in the previous paragraph).
Any 2-sided value of P<0.05 was considered significant. We did not correct P values for multiple comparisons because our analyses were hypothesis driven and the phenotypes of interest were highly correlated and nonindependent. Analyses were performed with R software version 3.0.2.
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RESULTS
Participants
Study design is available in Figure I in the online-only Data Supplement. We found no significant differences among groups in the baseline characteristics of the volunteers (Table) . Comparison of the baseline characteristics between our subsample and the whole population of the PREDIMED trial (Table I in the online-only Data Supplement) shows that our volunteers were on average 1.1 years older and there were 6.8% more men. However, no other differences in the main clinical characteristics were observed. Energy expenditure in leisuretime physical activity and caloric intake did not change throughout the study, and volunteers' compliance with the interventions was correct according to biomarkers of compliance, TMD adherence scores, and the 1-year food frequency questionnaire (Tables II and III in the online-only Data Supplement). Increased adherence to TMD after the TMD-VOO intervention was due to increases in the consumption of virgin olive oil, legumes, and fish; substitution of red/processed meat for white meat; and decreases in the consumption of precooked foods and industrial sweets (P<0.05). Increased adherence to TMD after the TMD-Nuts intervention was due to increases in the consumption of nuts, virgin olive oil (less than in the TMD-VOO intervention), fruits, vegetables, and oily fish and decreases in the consumption of red and processed meat, precooked meals, and industrial sweets (P<0.05). Last, adherence to a low-fat diet was observed as a decrease in total fat intake (particularly saturated fats) resulting from decreases in the consumption of high-fat dairy products, red and processed meat, precooked meals, and industrial sweets (P<0.05).
Lipids
In terms of the biochemical profile of the participants (Tables IV and V in the online-only Data Supplement), we observed an expected decline in total cholesterol levels after the low-fat control diet (P=0.039 and P=0.007 relative to baseline and the TMD-VOO intervention, respectively). This was due mainly to a decrease in LDL cholesterol levels (P=0.019 and P=0.004 relative to baseline and the TMD-VOO intervention, respectively).
In terms of the HDL-related biochemical profile, we did not observe significant changes in HDL-C or ApoA-I levels in any intervention relative to baseline or the lowfat diet ( Figure 1A-1D ). However, there was a significant decrease in the HDL-C/ApoA-I ratio values in plasma in the TMD interventions relative to baseline (P=0.031 and P<0.001 in the TMD-VOO and TMD-Nuts intervention, respectively) but not relative to the low-fat diet.
Cholesterol Efflux Capacity
The cholesterol efflux capacity of the volunteers increased with both TMD interventions relative to baseline (P=0.018 and P=0.013 for TMD-VOO and TMD-Nuts, respectively; Figure 1E and 1F) but not relative to the low-fat diet.
HDL Role in Other Steps of Reverse Cholesterol Transport
The ability of HDL particles to esterify cholesterol (the HDL-C esterification index) increased significantly after the TMD-VOO intervention relative to baseline (P=0.007) and compared with the low-fat control intervention (P=0.039; Figure 1G and 1H).
CETP activity ( Figure 1I and 1J) decreased significantly after the TMD-VOO intervention relative to baseline (P=0.008) but not compared with the low-fat diet.
HDL Antioxidant Capacities
PON1 arylesterase activity did not change significantly relative to baseline after any intervention. However, compared with the low-fat diet, it increased after the TMD-VOO intervention (P=0.012; Figure 2A and 2B).
The HDL capacity to directly counteract LDL oxidation rose after the TMD-VOO intervention relative to baseline values (P=0.004) but not compared with the low-fat diet ( Figure 2C and 2D) .
With respect to other antioxidant/anti-inflammatory properties of HDL, the HII increased significantly after the low-fat control diet relative to baseline (P=0.025), whereas it did not rise after the TMD interventions (Figure 2E and 2F) . This led to a borderline significant decrease in HII values after the TMD-Nuts intervention relative to the low-fat diet (P=0.060).
HDL Vasodilatory Capacity
The ability of HDL to promote the production of nitric oxide in endothelial cells (HDL vasodilatory capacity) did not change significantly relative to baseline after any intervention. However, it increased significantly after the TMD-VOO intervention relative to the low-fat diet (P=0.026; Figure 3A and 3B). 
HDL Oxidation
The level of oxidation of HDL particles (HDL oxidation index) decreased after the TMD-VOO and the low-fat control diet relative to their baseline values (P=0.028 and P=0.011, respectively; Figure 4A and 4B). HDL dynamic resistance against oxidation (HDL oxidation lag time) increased after the TMD-VOO intervention relative to baseline values (P=0.006) but not compared with the low-fat diet ( Figure 4C and 4D) .
HDL Composition
Compared with the low-fat diet, the content of triglycerides in HDL core decreased significantly after both the TMD-VOO and TMD-Nuts interventions (P=0.027 and P=0.035, respectively; Figure 4E and 4F). After the TMD-VOO intervention, the content of phospholipids in the HDL surface increased relative to baseline (P=0.003) and the low-fat control diet (P=0.036) ( Figure 4G and 4H) .
We found no significant changes in the levels of ApoA-I and apolipoproteins A-II and C-III in HDL in any of the interventions.
HDL Size Distribution
The 3 interventions increased the levels of large HDL particles relative to their baseline values (P<0.001 for the 3 interventions; Figure 4I and 4J). We observed no differences among the 3 interventions in the multivariate regression model.
Other Data
All values of the comparisons between postintervention and preintervention values and between the changes in the TMD interventions relative to the low-fat diet are available in Tables VI and VII in Supplement. Further description of the relationships among baseline and changes in HDL functionality traits is available in the Results section in the online-only Data Supplement.
DISCUSSION
Our results show that 1 year of intervention with a TMD improves several HDL functions (cholesterol efflux capacity, cholesterol metabolism, antioxidant/anti-inflammatory properties, and vasodilatory capacity) in individuals at high cardiovascular risk. Thus far, this randomized controlled trial is the largest (n=296) and longest-duration (1.13±0.21 years [mean±SD]) study assessing change in HDL functionality in humans.
Cholesterol efflux capacity is a key biological function of HDL: HDL particles extract excess cholesterol from peripheral cells for delivery to the liver for metabolization or excretion. 24 Macrophage-specific cholesterol efflux capacity is inversely related to higher cardiovascular risk 17 and greater incidence of coronary events. 25 In the present trial, both TMD interventions increased cholesterol efflux capacity relative to baseline. We assessed cholesterol efflux capacity in a human THP-1 macrophage-based model because these cells do not require a chemical induction of the expression of the cholesterol transporters before the experiments 26 and reflect more physiologically the efflux phenomenon and the overall human atherosclerotic process. 24 An improved HDL oxidative status 27 (as has been associated in our data), lipid composition, 12 and HDL-related gene expression 28 may contribute to explaining these changes. Similar increments in cholesterol efflux capacity using the same human macrophage model have been observed in clinical trials with virgin olive oil 11 and trials with supplements of polyunsaturated fatty acids. 14 HDL lipoproteins esterify and internalize accepted cholesterol from the periphery, continuing the reverse cholesterol transport pathway. 29 This property can be measured by LCAT activity 29 or the HDL-C esterification index. In our study, the TMD-VOO intervention significantly increased the HDL-C esterification index. Because LCAT is very sensitive to oxidative attacks, 30 dietary antioxidants in the TMD may contribute to maintaining LCAT nonoxidized and functional. A fruit and vegetable-rich diet 31 and a supplement of the antioxidant lycopene 13 have induced similar effects in previous studies. CETP is a key enzyme in the cholesterol transfer from HDL particles to triglyceride-poor lipoproteins (and subsequently to the liver). CETP activity is frequently increased in high-cardiovascular-risk states. 32 However, inhibition of CETP with pharmacological agents has not resulted in improved cardiovascular outcomes. 33 It has been hypothesized that this lack of effects could be due to the futility of drastically increasing HDL-C levels above physiological concentrations or to harmful off-target effects (eg, hypertensive ones). 33 Nevertheless, a slight decrease in the CETP activity (such as that present after the TMD-VOO intervention in this trial [2.90%] or after a lycopene-rich diet 13 [5.87%]), accompanied by a general improvement in the lipid metabolism profile and without off-target effects, may be protective because it could contribute to maintaining HDL homeostatic function.
Another key atheroprotective role of HDL is its antioxidant capacity. HDL lipoproteins are able to counteract the oxidation of LDL, one of the main biochemical triggers of the development of the atherosclerotic plaque. 10 This antioxidant capacity is coordinated through the action of several proteins, among which PON1 is the central enzyme. 34 Although low PON1 arylesterase activity has been postulated as a potential predictor of cardiac events in some trials, 35 its predictive role is still controversial in other human studies. 36 In the present trial, the TMD-VOO intervention increased the overall antioxidant protection of HDL particles on LDLs and incremented PON1 arylesterase activity. This augmentation in PON1 function seemed independent of the benefits of the TMD-VOO intervention on other HDL functions. Although not directly assessed in this study, the different bioactive compounds in the TMD (olive oil phenolic compounds, 18 carotenoids such as lycopene, 13 and omega-3 polyunsaturated fatty acids 14 ) may act synergistically and could induce local antioxidant functions, preserve other dietary antioxidants in HDL lipoproteins (such as vitamin E), and protect PON1 against oxidative modifications or enhance its function. 37, 38 HDL particles can also counteract the proinflammatory effects of pro-oxidant substances such as modified LDL as a result of the combined action of HDL-associated proteins. 19, 34 Low HII values reflect an increase in HDL anti-inflammatory properties. 19 HII has been shown to be abnormally elevated in subjects with cardiovascular pathologies and can discriminate patients with acute coronary syndrome from those with stable angina or healthy control subjects. 19 In the present study, the low-fat control diet increased HII values, but the TMD interventions did not. Further studies are warranted because to date no diet-based intervention has been shown to be able to improve the HII significantly.
In addition to cholesterol transport, antioxidative, and anti-inflammatory functions, HDL lipoproteins have endothelial vasoprotective properties, 39 which are impaired in high-cardiovascular-risk states. 40 In the present trial, the TMD-VOO intervention increased the capacity of isolated HDL to induce the production of nitric oxide from endothelial cells, a vasodilatory trait (which can also be considered vasoprotective). This increase in HDL endothelial protection seemed to be independent of the benefits of the TMD-VOO intervention on other HDL functions, as in the case of the improvement in the PON1 function. HDL particles with a high content of sphingosine-1-phosphate, a low content of oxidized lipids, and a stronger capacity to perform ABCG1-dependent cholesterol efflux have been associated with a greater ability to maintain endothelial homeostasis. 39 Weight losses resulting from gastric surgery 20 and an aerobic exercise training program 41 have increased the ability of HDL to induce the release of nitric oxide from endothelial cells in previous trials. However, TMD is the first dietary modification that has been shown to promote HDL vasoprotective properties. A potential explanation for the TMD-mediated increase in HDL functionality could be an improvement in the oxidative status of the lipoprotein. 27 In our trial, although the TMD-VOO intervention and the low-fat diet led to a decreased oxidation of HDL particles, the lipoproteins were more resistant against dynamic oxidation only after the TMD-VOO intervention. Both the TMD-VOO and low-fat interventions were rich in fruits and vegetables. 15 Some antioxidants such as carotenoids are highly present in both, bind to HDL lipoproteins, and protect them locally against oxidative modifications. 13 However, antioxidant protection could be greater in the TMD because of a higher content of its particular antioxidants such as olive oil phenolic compounds. 11, 38 Another mechanism that could explain the benefits of the TMD on HDL function could be a better HDL composition profile. Both TMD interventions decreased the content of triglycerides in the HDL core. Low-fat diets are known to induce transient hypertriglyceridemias, 42 which could lead to an indirect hypertriglyceridemic state in HDL particles. Nevertheless, HDL hypertriglyceridemias appeared to be reversed by the TMD in our trial. In the specific case of the TMD-VOO intervention, the decreased CETP activity could help to explain the reduced triglyceride content in HDL lipoproteins, as observed in our data. In the particular case of the TMD-Nuts intervention, the nut consumption may have decreased systemic triglyceride levels 43 and indirectly reduced HDL triglyceride content. These decrements in the HDL triglyceride content after the TMD interventions are associated with a more stable conformation of ApoA-I in the HDLs 44 and could partially explain the improved HDL role in cholesterol efflux capacity and antioxidant functions.
Continuing with HDL composition, after the TMD-VOO intervention, HDL particles had more phospholipids in their surface. As has been associated in our data, the improved HDL capacity to esterify cholesterol may explain this change: When the free cholesterol content in the surface decreases, the relative content of phospholipids increases. This could be linked to a greater HDL fluidity, which has already been observed after the consumption of virgin olive oil 11, 38 and could contribute to explaining an increased HDL functionality.
Some parameters related to the structure of HDL such as the HDL-C/ApoA-I ratio in plasma also improved after the TMD interventions. A decrease in the HDL-C/ ApoA-I balance could be beneficial because high values of this ratio have been associated with increased cardiovascular and all-cause mortality. 45 Last, size is also a major but controversial trait of lipoproteins. Large HDL particles may be atheroprotective because of their ability to mediate ABCG1-and SRBIdependent cholesterol efflux capacity, whereas small and lipid-free HDL lipoproteins could also be beneficial through their ability to promote the ABCA1-dependent efflux phenomenon. 24, 46 The ability of the TMD and some of its bioactive components (olive oil phenolic compounds) to increase the levels of large HDL particles has already been described in previous trials. 11, 47 The present study has several strengths. First, it involves a large sample size (n=296). Second, it presents a randomized design with the presence of an active comparator (low-fat diet). Third, its duration is long (1 year of follow-up). Last, it comprehensively assesses diverse HDL functions and HDL quality-related characteristics. Nevertheless, it also has limitations. The participants of the trial were elderly people at high cardiovascular risk, which hinders the extrapolation of our results to the general population. As expected, we found only slight differences because the trial is based on modest real-life modifications of the diet and the control diet is already a well-known healthy dietary pattern. The use of cellular models, although a noninvasive alternative to test relevant physiological functions, may not have demonstrated the effect of contraregulatory mechanisms, which can modify the final in vivo outcome in humans. Because of availability issues, in the samples from 2 study centers (n=67), we could not perform the analyses related to HDL main enzymatic proteins (CETP and PON1 activities and LCAT mass). In the samples from 1 study center (n=37), we were also unable to assess HDL size. Last, we could not perform HDL vasodilatory capacity analyses in 16% of the individuals in all the interventions because of technical issues in cell cultures.
CONCLUSIONS
We report the effects of an integral dietary intervention on HDL functionality. To date, this is the first randomized controlled trial to study simultaneously 4 key HDL functional traits (cholesterol efflux capacity, HDL-C metabolism, HDL antioxidant/anti-inflammatory properties, and vasoprotective effects) in a large sample size and with an extended duration of the intervention. Adherence to a TMD, especially when enriched with virgin olive oil, was associated with increases in these 4 key HDL functions. The TMD could have induced these benefits through improvements in HDL oxidative status, composition, and size. Our data support the improvement in HDL function after following a TMD. Further studies are warranted to investigate the mechanism by which the TMD improves HDL function and whether these properties convey cardioprotective effects.
